"Biocartis Group NV...announce that they entered into a collaboration that will initially focus on the commercialization of ColoNode, a CE-marked IVD gene expression signature test that can help detect nodal metastasis in colorectal cancer (CRC) patients. ColoNode will be distributed as a manual kit by Biocartis to expert laboratories in selected European countries."